Minerva Neurosciences Inc., trading on the Nasdaq global market under the ticker symbol NERV, holds a live share price of approximately five dollars. Because clinical-stage pharmaceutical equities experience rapid intraday price movements driven by regulatory updates, clinical trial announcements, and broader market sentiment, investors seeking exact, real-time pricing data for portfolio execution should verify live brokerage quotes immediately prior to placing orders on the exchange.